Sanofi
SNY • Drug Manufacturers - General
$41.44
▲ +0.04 (+0.10%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHLY FAVORABLE PROFILEExcellentConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$99.54B
Growth
6.6%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 16.7%Positive revenue growth · 5.2%Positive free cash flow · 4.16Consistent free cash flow · 5/5Reasonable earnings multiple · 12.88
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 23, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:27 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$41.44
Change0.10%
Shares Out2.41B
Market Cap$99.54B
52W Range40.89 - 52.68
Beta0.28
P/E14.98
P/S8.60
P/B1.33
P/FCF0.00
EV/Sales10.22
EV/EBITDA42.29
Price$41.44
Change0.10%
Shares Out2.41B
Market Cap$99.54B
52W Range40.89 - 52.68
Beta0.28
P/E14.98
P/S8.60
P/B1.33
P/FCF0.00
EV/Sales10.22
EV/EBITDA42.29
EV/FCF0.00
Earnings Yield6.67%
FCF Yield0.00%
Dividend Yield0.00%
Gross Margin72.07%
Oper. Margin20.54%
Profit Margin16.72%
Debt/Eq0.31
Current Ratio1.09
Quick Ratio0.29
Revenue 5Y6.57%
FCF 5Y10.88%
Target$49.00
Target Upside18.24%
Target Median$49.00
Target Range49.00 - 49.00
Volume10.18M
Avg Volume3.26M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
83
out of 100
Business Quality
Margins, moat, returns
85/100
Financial Strength
Debt, cash, stability
64/100
Growth Potential
Revenue and expansion
71/100
Price Attractiveness
Cheap or expensive today
87/100
Why this score▼
Stable or improving margins · 16.7%Positive revenue growth · 5.2%Positive free cash flow · 4.16Consistent free cash flow · 5/5Reasonable earnings multiple · 12.88Manageable debt level · 0.31
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 27 analyst votes · 2026-10-20
70/100
Bullish
Bullish
12
Hold
14
Bearish
1
Price Target
2026-07-31
Low
$49.00
Mean
$49.50
Median
$49.50
High
$50.00
🧾
No insider activity
No recent insider transactions available.